TScan Therapeutics, Inc. (TCRX) key performance indicators and operating metrics (1 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Collaboration and License Revenue | 982K | FY2026-Q1 |
Back to TCRX overview · TCRX earnings · TCRX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.